New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
05:18 EDTSLXPSalix, Pharming Group announces extension of PDUFA action date for Ruconest
Pharming Group NV and Salix Pharmaceuticals announced that the FDA has extended the Prescription Drug User Fee Act, or PDUFA, Action Date to July 16 for the company's Biologics License Application, or BLA, for the investigational drug Ruconest 50 IU/kg. Pharming and Salix are seeking U.S. marketing approval of Ruconest for the treatment of acute angioedema attacks in patients with hereditary angioedema.
News For SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
18:18 EDTSLXPGlenview Capital acquires stake in Actavis, Bloomberg reports
Subscribe for More Information
October 21, 2014
07:07 EDTSLXPSalix to present results of TARGET 3 study with Rifaximin 550mg for IBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use